Literature DB >> 8676114

Cementless total knee arthroplasty in rheumatoid arthritis. A report on 51 AGC knees followed for 54 months.

H M Schrøder1, K Aaen, E B Hansen, P T Nielsen, K Rechnagel.   

Abstract

Fifty-one primary consecutive cementless AGC 2000 (Anatomically Graduated Components, Biomet, Warsaw, IN) total knee arthroplasties were performed during 1985 through 1990 in 40 patients with rheumatoid arthritis. Forty-one knees (32 patients) were available for clinical and radiologic follow-up analysis after 24 to 76 months (median, 54 months). There was no pain in 33 knees and mild pain in the rest. Median range of motion was 110 degrees (range, 50 degrees-130 degrees). Median knee score was 90 (range, 71-97), and all knees were rated good or excellent. Radiolucencies greater than 1 mm were found under five tibial components, but no obvious migrations were seen. One tibial component was revised due to aseptic loosening. The cumulative success rate after 4 to 5 years was 97% (lower limit of 95% confidence interval, 91.8%). The medium-term results are considered to compare favorably with reported cemented series.

Entities:  

Mesh:

Year:  1996        PMID: 8676114     DOI: 10.1016/s0883-5403(96)80157-4

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

Review 1.  Validity of published outcome data concerning Anatomic Graduated Component total knee arthroplasty: a structured literature review including arthroplasty register data.

Authors:  Reinhard Schuh; Gerald Dorninger; Mark Agreiter; Nikolaus Boehler; Gerold Labek
Journal:  Int Orthop       Date:  2011-04-13       Impact factor: 3.075

2.  Cementless total knee arthroplasty in chronic inflammatory rheumatism.

Authors:  Jonathan Buchheit; Antoine Serre; Xavier Bouilloux; Marc Puyraveau; Laurent Jeunet; Patrick Garbuio
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-17

3.  Clinical results of bone ingrowth TKA in patients with rheumatoid arthritis.

Authors:  Roberto Viganó; Leo A Whiteside; Marcel Roy
Journal:  Clin Orthop Relat Res       Date:  2008-07-24       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.